 |
|
The Structural Basis of Familial Hypertrophic Cardiomyopathy is Revealed
November 12, 2007Familial Hypertrophic Cardiomyopathy (FHC), the leading cause of sudden death in athletes and young people, is a genetic disorder of the heart that is characterized by an increased thickness in tissue of the left ventricle. FHC is thought to be caused by a mutation in the myosin heavy chain, one of the components of muscle cells in the heart, which causes a disruption in the normal alignment of muscle cells otherwise known as myocardial disarray. One of the deadliest forms of FHC is caused by the R403Q mutation, which kills 50% of those affected individuals by 40 years of age. A study conducted by scientists at the Burnham Institute for Medical Research (Burnham Institute) in La Jolla, CA provides new structural evidence that the disarray at the molecular level caused by the R403Q point mutation in myosin is linked to the characteristic misalignment of muscle cells in FHC.
In a recent publication by PloS ONE, the scientific group, led by Dr. Dorit Hanein (Burnham Institute), used smooth muscle myosin to investigate the structural effects of the R403Q mutation. The group concluded that this point mutation severely disrupts actin-myosin interactions as compared to those in wildtype myosin. While myosin normally attaches to the actin filament at a fixed angle, the mutated myosin displayed a wide variety of angles at the attachment sites, thus demonstrating a structural basis for the change in function of the mutant myosin. Dr. Hanein illustrates how the conformational instability within the sarcomere affects ability of the heart to function properly and may lead to compensatory hypertrophy in cardiac muscle tissue, which is a trademark phenotype of FHC. This study allows for a better understanding of the origination of FHC at the molecular level, which may open doors for the development of drugs to treat this disorder in the future.
Dr. Dorit Hanein is an Associate Professor within the Infectious Diseases Program at the Burnham Institute for Medical Research. The study was conducted in collaboration with the University of Vermont Department of Molecular Physiology and Biophysics.
Burnham Institute for Medical Research conducts world-class collaborative research dedicated to finding cures for human disease, improving quality of life, and thus creating a legacy for its employees, partners, donors, and community. The La Jolla, California campus was established as a nonprofit, public benefit corporation in 1976 and is now home to three major centers: a National Cancer Institute-designated Cancer Center, the Del E. Webb Center for Neuroscience, Aging, and Stem Cell Research, and the Infectious and Inflammatory Disease Center. Burnham today employs nearly 800 people, ranks consistently among the world's top 20 organizations for the impact of its research publications, and rates fourth among all research institutes in the United States for obtaining grant funds from the National Institutes of Health. In 2006, Burnham established a center for vascular mapping and bionanotechnology in Santa Barbara, California. Burnham is also establishing a campus at Lake Nona in Orlando, Florida that will focus on diabetes and obesity research and will expand the Institute's drug discovery capabilities, employing over 300 people. For additional information about Burnham and to learn about ways to support its research, visit http://www.burnham.org.
Burnham Institute for Medical Research
Burnham Institute for Medical Research conducts world-class collaborative research dedicated to finding cures for human disease, improving quality of life, and thus creating a legacy for its employees, partners, donors, and community. The La Jolla, California campus was established as a nonprofit, public benefit corporation in 1976 and is now home to three major centers: a National Cancer Institute-designated Cancer Center, the Del E. Webb Center for Neuroscience, Aging, and Stem Cell Research, and the Infectious and Inflammatory Disease Center. Burnham today employs nearly 800 people, ranks consistently among the world's top 20 organizations for the impact of its research publications, and rates fourth among all research institutes in the United States for obtaining grant funds from the National Institutes of Health. In 2006, Burnham established a center for vascular mapping and bionanotechnology in Santa Barbara, California. Burnham is also establishing a campus at Lake Nona in Orlando, Florida that will focus on diabetes and obesity research and will expand the Institute's drug discovery capabilities, employing over 300 people. For additional information about Burnham and to learn about ways to support its research, visit http://www.burnham.org.
Burnham Institute for Medical Research
Myosin News and Current Myosin Events RSSDense tissue promotes aggressive cancers
New research may explain why breast cancer tends to be more aggressive in women with denser breast tissue. Breast cancer cells grown in dense, rigid surroundings step up their invasive activities, Vanderbilt-Ingram Cancer Center investigators report in the Sept. 9 issue of Current Biology.
Molecular motor works by detecting minute changes in force
Researchers at the University of Pennsylvania School of Medicine discovered that the activity of a specific family of nanometer-sized molecular motors called myosin-I is regulated by force. The motor puts tension on cellular springs that allow vibrations to be detected within the body.
UIC researchers make promising finding in severe lung disease
Researchers at the University of Illinois at Chicago have identified a novel function for an enzyme that plays a role in the tissue injury in acute respiratory distress syndrome, also known as ARDS.
Ancient protein offers clues to killer condition
More than 600 million years of evolution has taken two unlikely distant cousins - turkeys and scallops - down very different physical paths from a common ancestor. But University of Leeds researchers have found that a motor protein, myosin 2, remains structurally identical in both creatures.
Researchers find new way to block destructive rush of immune cells
Researchers have found a way to selectively block the ability of white blood cells to "crawl" toward the sites of injury and infection when such mobility drives disease, according to a study published today in The Journal of Experimental Medicine.
Scripps Research scientists reveal pivotal hearing structure
In a study published in the September 6, 2007, issue of the journal Nature, researchers showed that two key proteins join together at the precise location where energy of motion is turned into electrical impulses.
A stepwise retreat: how immune cells catch pathogens
To protect us from disease our immune system employs macrophages, cells that roam our body in search of disease-causing bacteria.
Molecular motors may speed nutrient processing
Matthew Tyska, Ph.D., recalls being intrigued, from the first day of his postdoctoral fellowship in 1999, with a nearly 30-year-old photograph. It was an electron micrograph that showed the internal structures of an intestinal cell microvillus, a finger-like protrusion on the cell surface. Microvilli are common features on the epithelial cells that line the body's cavities.
Researchers find level of special protein is critical to proper formation of muscles
Proper formation of the proteins that power heart and skeletal muscle seems to rely on a precise concentration of a "chaperone" protein known as UNC-45, according to a new study.
Tiny molecule controls stress-induced heart disease
A tiny snippet of RNA, a chemical cousin of DNA, controls damage to the heart under several types of stress, researchers at UT Southwestern Medical Center have found.
More Myosin News Articles
 | Myosins: A Superfamily of Molecular Motors (Proteins and Cell Regulation) (Proteins and Cell Regulation) This volume highlights the remarkable superfamily of molecular motors called myosins, which are involved in such diverse cellular functions as muscle contraction, intracellular transport, cell migration and cell division. In a timely compilation of chapters written by some of the leading research groups in the world that have made key discoveries in the field, the current understanding of the... |
| Muscle protein (The biochemistry of tissue trauma) by Carroll A Handley | |
 | Mechanism of Myofilament Sliding in Muscle Contraction (Advances in Experimental Medicine and Biology) |
| Molecular Mechanisms of Smooth Muscle Contraction (Molecular Biology Intelligence Unit) This book explains how smooth muscle contracts through the interaction of myosin with actin, within the context of recent developments in molecular biology. The key enzyme that phosphorylates myosin to convert it from the inactive form to the active form is myosin light chain kinase. The structure and function of this enzyme are described together with the recent findings of its actin-and... | |
| Myosinoses (Trans. Conn. Acad) by W Ku?hne | |
| Studies on adenosinetriphosphatase in muscle I;: Concentration of the enzyme on myosin by B. David Polis | |
| Myosin Heavy Chain (MHC) Isoenzymes: A New Method for Analysis and Aspects of Their Heterogeneous Distribution in Normoxic and Postischemic Hearts (Berichte Aus Der Medizin) by Pomblum Garcia, Cristina Solange | |
| Progress report: Comparative biochemical studies of muscle proteins (IMR) by H. S Olcott | |
| Cytoplasmic and skeletal myosin: Localization within the same cells; by Justin R Fallon | |
| cAMP regulation of myosin isozymes in the maturing rat heart: A dissertation in physiology by Robert Horowits |
| © 2008 BrightSurf.com |